Aurinia Pharmaceuticals (AUPH) Operating Margin (2019 - 2026)
Aurinia Pharmaceuticals posted quarterly Operating Margin of 53.31% for Q1 2026, up 1833.0% year-on-year from 2.76% in Q1 2025, and up 23.67% on a QoQ basis from 43.1% in Q4 2025.
Aurinia Pharmaceuticals (AUPH) has 8 years of Operating Margin data on file, last reported at 53.31% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin rose 1833.0% year-over-year to 53.31%; the trailing twelve-month figure through Mar 2026 stood at 41.73% (up 2944.0% YoY), and the FY2025 full-year result was 37.06%, up 3906.0% from the prior year.
- Operating Margin for Q1 2026 stood at 53.31%, up from 43.1% in the prior quarter.
- Across five years, Operating Margin topped out at 53.31% in Q1 2026 and bottomed at 175.18% in Q1 2022.
- The 5-year median for Operating Margin is 17.03% (2022), against an average of 26.66%.
- The widest annual swing landed in 2022, when Operating Margin soared 535469 bps; it then sank 1280 bps in 2023.
- A 5-year view of Operating Margin shows it stood at 98.82% in 2022, then soared by 33 bps to 65.8% in 2023, then soared by 96 bps to 2.79% in 2024, then jumped by 1646 bps to 43.1% in 2025, then advanced by 24 bps to 53.31% in 2026.
- The last three Operating Margin figures came in at 53.31% (Q1 2026), 43.1% (Q4 2025), and 40.49% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.02% |
| 10 | Aurinia Pharmaceuticals | 2.03 Bn | 1.65 Bn | 71.20 Mn | 53.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.31% |
| Dec 31, 2025 | 43.10% |
| Sep 30, 2025 | 40.49% |
| Jun 30, 2025 | 28.69% |
| Mar 31, 2025 | 34.97% |
| Dec 31, 2024 | -2.79% |
| Sep 30, 2024 | 17.33% |
| Jun 30, 2024 | -2.65% |
| Mar 31, 2024 | -26.35% |
| Dec 31, 2023 | -65.80% |
| Sep 30, 2023 | -29.83% |
| Jun 30, 2023 | -38.97% |
| Mar 31, 2023 | -85.98% |
| Dec 31, 2022 | -98.82% |
| Sep 30, 2022 | -17.03% |
| Jun 30, 2022 | -127.66% |
| Mar 31, 2022 | -175.18% |
| Dec 31, 2021 | -139.74% |
| Sep 30, 2021 | -343.31% |
| Jun 30, 2021 | -711.99% |
| Mar 31, 2021 | -5,529.87% |
| Dec 31, 2020 | -16.09% |
| Sep 30, 2020 | -145,913.79% |
| Jun 30, 2020 | -92,631.03% |
| Dec 31, 2019 | -120,141.38% |